Welgus Howard G. bought ARQT
June 15, 2026 · Form 4 insider transaction
Welgus Howard G. bought 1,019 shares of Arcutis Biotherapeutics, Inc. at $7.51 per share, a transaction worth $7.7K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,019
Price
$7.51
Total value
$7.7K
InsiderWelgus Howard G.
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 15, 2026
Filing dateJune 17, 2026
Shares owned after40,219
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027.